Prevalence of autism spectrum disorder phenomenology in genetic disorders: a systematic review and meta-analysis.

BACKGROUND Autism spectrum disorder (ASD) phenomenology is reported to be more common in individuals with some genetic syndromes than in the general population; however, no meta-analysis has provided prevalence data within and between syndromes. In this systematic review and meta-analysis, we aimed to synthesise data from a wide range of papers to provide accurate estimates about ASD phenomenology in genetic and metabolic syndromes. METHODS We identified syndromes reported as most likely to be associated with ASD. We searched Ovid PsycINFO, Ovid MEDLINE, Ovid Embase, and PubMed Central for English-language papers published from database creation up to early 2014 with use of syndrome-specific keywords and a set of ASD keywords. We screened and extracted papers that had ASD prevalence data for ten or more people within a genetic syndrome. With use of a prespecified set of reliable criteria, we applied quality weighting to papers and estimated a quality-effects prevalence of ASD phenomenology for each syndrome. We then calculated relative risks to compare ASD between all syndromes and also calculated odds ratios to compare prevalence with the general population taking the current estimate of one in 68 people. RESULTS We identified 168 papers reporting the prevalence of ASD phenomenology and found widely varying methods and quality of data. Quality-weighted effect prevalence estimates of ASD phenomenology were established for Rett's syndrome (female individuals only 61%), Cohen's syndrome (54%), Cornelia de Lange syndrome (43%), tuberous sclerosis complex (36%), Angelman's syndrome (34%), CHARGE syndrome (30%), fragile X syndrome (male individuals only 30%; mixed sex 22%), neurofibromatosis type 1 (18%), Down's syndrome (16%), Noonan's syndrome (15%), Williams' syndrome (12%), and 22q11.2 deletion syndrome (11%). Relative risks and the odds ratio compared with the general population were highest for Rett's syndrome and Cohen's syndrome. In all syndromes, odds ratios showed ASD phenomenology to be significantly more likely than in the general population. INTERPRETATION ASD phenomenology varied between syndromes, but was consistently more likely than in the general population. Further research is needed in these populations, including how ASD in genetic and metabolic syndromes differs from idiopathic autism and what that can tell us about the mechanisms underlying ASD. FUNDING Cerebra.

[1]  F. Happé,et al.  Time to give up on a single explanation for autism , 2006, Nature Neuroscience.

[2]  Tony Charman,et al.  Measurement Issues: Screening and diagnostic instruments for autism spectrum disorders - lessons from research and practice. , 2013, Child and adolescent mental health.

[3]  J. Moss,et al.  Delineation of Behavioral Phenotypes in Genetic Syndromes: Characteristics of Autism Spectrum Disorder, Affect and Hyperactivity , 2011, Journal of autism and developmental disorders.

[4]  C. Gillberg,et al.  Autism spectrum conditions in individuals with Möbius sequence, CHARGE syndrome and oculo-auriculo-vertebral spectrum: diagnostic aspects. , 2010, Research in developmental disabilities.

[5]  C. Rice.  Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. , 2009, Morbidity and mortality weekly report. Surveillance summaries.

[6]  J. Matson,et al.  Intellectual disability and its relationship to autism spectrum disorders. , 2009, Research in developmental disabilities.

[7]  D. Zafeiriou,et al.  Autism spectrum disorders: The quest for genetic syndromes , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[9]  J. Moss,et al.  The assessment and presentation of Autism Spectrum Disorder and associated characteristics in individuals with severe intellectual disability and genetic syndromes , 2011 .

[10]  S. Hall,et al.  Behavioural phenotype of Cornelia de Lange syndrome: case–control study , 2008, British Journal of Psychiatry.

[11]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[12]  N. Black,et al.  The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. , 1998, Journal of epidemiology and community health.

[13]  D. Geschwind,et al.  Genetic advances in autism: heterogeneity and convergence on shared pathways. , 2009, Current opinion in genetics & development.

[14]  Chris Oliver,et al.  Prevalence of autism spectrum disorder symptomatology and related behavioural characteristics in individuals with Down syndrome , 2013, Autism : the international journal of research and practice.

[15]  T. Bourgeron,et al.  Searching for ways out of the autism maze: genetic, epigenetic and environmental clues , 2006, Trends in Neurosciences.

[16]  J. Moss,et al.  Prevalence of autism spectrum phenomenology in Cornelia de Lange and Cri du Chat syndromes. , 2008, American journal of mental retardation : AJMR.

[17]  D. Zafeiriou,et al.  Childhood autism and associated comorbidities , 2007, Brain and Development.

[18]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[19]  Martien JH Kas,et al.  Behavioral signatures related to genetic disorders in autism , 2014, Molecular Autism.

[20]  G. Baird,et al.  Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP) , 2006, The Lancet.

[21]  P. Howlin,et al.  Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. , 2009, Journal of intellectual disability research : JIDR.

[22]  E. Fombonne,et al.  The epidemiology of autism: a review , 1999, Psychological Medicine.

[23]  D. Moher,et al.  Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists. , 2011, Journal of clinical epidemiology.

[24]  P. Bolton,et al.  Genetic heterogeneity between the three components of the autism spectrum: a twin study. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  A. Reiss,et al.  Autism in fragile X syndrome: a category mistake? , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  D. Skuse.  Rethinking the nature of genetic vulnerability to autistic spectrum disorders. , 2007, Trends in genetics : TIG.

[27]  S. Hall,et al.  Delineating the profile of autism spectrum disorder characteristics in Cornelia de Lange and Fragile X syndromes. , 2013, American journal on intellectual and developmental disabilities.